Pacira Biosciences, Stock Price on June 27, 2024
| PCRX Stock | USD 19.65 0.16 0.81% |
Below is the normalized historical share price chart for Pacira BioSciences, extending back to February 03, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pacira BioSciences, stands at 19.65, as last reported on the 29th of December, with the highest price reaching 20.04 and the lowest price hitting 19.47 during the day.
If you're considering investing in Pacira Stock, it is important to understand the factors that can impact its price. Pacira BioSciences, appears to be very steady, given 3 months investment horizon. Pacira BioSciences, maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pacira BioSciences,, which you can use to evaluate the volatility of the company. Please evaluate Pacira BioSciences,'s Coefficient Of Variation of 512.54, semi deviation of 1.92, and Risk Adjusted Performance of 0.1628 to confirm if our risk estimates are consistent with your expectations.
At this time, Pacira BioSciences,'s Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.7 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 32.8 K in 2024. . At this time, Pacira BioSciences,'s Price Earnings Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 11.74 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024. Pacira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2011 | 200 Day MA 21.4728 | 50 Day MA 17.881 | Beta 0.818 |
Pacira |
Sharpe Ratio = 0.1579
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PCRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Pacira BioSciences, is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pacira BioSciences, by adding it to a well-diversified portfolio.
Price Book 1.2104 | Enterprise Value Ebitda 32.8492 | Price Sales 1.3056 | Shares Float 45.7 M | Wall Street Target Price 18.125 |
Related Headline
Silver Spike Headline on 27th of June 2024
Acquisition by Scott Gordon of 14286 shares of Silver Spike ... by MacroaxisInsider
Filed transaction by Silver Spike Investment Director, 10 Percent Owner, Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Pacira BioSciences, Valuation on June 27, 2024
It is possible to determine the worth of Pacira BioSciences, on a given historical date. On June 27, 2024 Pacira was worth 27.84 at the beginning of the trading date compared to the closed value of 27.91. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pacira BioSciences, stock. Still, in general, we apply an absolute valuation method to find Pacira BioSciences,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pacira BioSciences, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pacira BioSciences,'s related companies.
| Open | High | Low | Close | Volume | |
| 28.18 | 28.33 | 27.18 | 27.61 | 822,657 | |
06/27/2024 | 27.84 | 28.06 | 27.38 | 27.91 | 438,297 |
| 28.15 | 28.95 | 27.89 | 28.61 | 2,333,989 |
| Backtest Pacira BioSciences, | | | Pacira BioSciences, History | | | Pacira BioSciences, Valuation | Previous | Next |
Pacira BioSciences, Trading Date Momentum on June 27, 2024
| On June 28 2024 Pacira BioSciences, was traded for 28.61 at the closing time. The top price for the day was 28.95 and the lowest listed price was 27.89 . The trading volume for the day was 2.3 M. The trading history from June 28, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 2.51% . The trading delta at closing time against the current closing price is 24.83% . |
Pacira BioSciences, Fundamentals Correlations and Trends
By evaluating Pacira BioSciences,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pacira financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pacira BioSciences, Stock history
Pacira BioSciences, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pacira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pacira BioSciences, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pacira BioSciences, stock prices may prove useful in developing a viable investing in Pacira BioSciences,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 52 M | 35.9 M | |
| Net Income Applicable To Common Shares | 18.3 M | 19.2 M |
Pacira BioSciences, Quarterly Net Working Capital |
|
Pacira BioSciences, Stock Technical Analysis
Pacira BioSciences, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pacira BioSciences, Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Pacira BioSciences, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pacira BioSciences, December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Pacira BioSciences, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacira BioSciences, shares will generate the highest return on investment. By undertsting and applying Pacira BioSciences, stock market strength indicators, traders can identify Pacira BioSciences, entry and exit signals to maximize returns
Pacira BioSciences, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pacira BioSciences,'s price direction in advance. Along with the technical and fundamental analysis of Pacira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pacira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1628 | |||
| Jensen Alpha | 0.5543 | |||
| Total Risk Alpha | 0.4743 | |||
| Sortino Ratio | 0.2299 | |||
| Treynor Ratio | 22.11 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.